Screener
Bioventus BVS Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermLinesOfCredit.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|
| Tax withholdings on equity-based compensation | (1,338) | — |
| Payment of contingent consideration | — | (19,771) |
| Borrowing on revolver | — | 15,000 |
| Payment on revolver | — | (10,000) |
| Payments on long-term debt | (45,750) | — |
| Other, net | (461) | (412) |
| Net cash from financing activities | (46,576) | (13,716) |
| Effect of exchange rate changes on cash | (978) | 632 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's debt repayments?
- Bioventus (BVS) reported debt repayments of $0 in Q2 2026.
- How has Bioventus's debt repayments changed year-over-year?
- Bioventus's debt repayments decreased by 100.0% year-over-year, from $5M to $0.
- What is the long-term trend for Bioventus's debt repayments?
- Over 4 years (2021 to 2025), Bioventus's debt repayments has grown at a 22.5% compound annual growth rate (CAGR), from $20M to $45M.
- What does debt repayments mean?
- Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.
Ask your AI about Bioventus's debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude